<?xml version="1.0" ?>
<document id="910a5b6256028ed6f3d360a28f14f49488b56db4">
  <chunk id="910a5b6256028ed6f3d360a28f14f49488b56db4.c0" text="Recent Developments in Peptide-Based Nucleic Acid Delivery">
    <entity charOffset="37-49" id="910a5b6256028ed6f3d360a28f14f49488b56db4.c0.e0" ontology_id="CHEBI_33696" text="Nucleic Acid" type="chemical"/>
    <entity charOffset="45-49" id="910a5b6256028ed6f3d360a28f14f49488b56db4.c0.e1" ontology_id="CHEBI_37527" text="Acid" type="chemical"/>
  </chunk>
  <chunk id="910a5b6256028ed6f3d360a28f14f49488b56db4.c1" text="Despite the fact that non-viral nucleic acid delivery systems are generally considered to be less efficient than viral vectors, they have gained much interest in recent years due to their superior safety profile compared to their viral counterpart. Among these synthetic vectors are cationic polymers, branched dendrimers, cationic liposomes and cellpenetrating peptides (CPPs). The latter represent an assortment of fairly unrelated sequences essentially characterised by a high content of basic amino acids and a length of 10-30 residues. CPPs are capable of mediating the cellular uptake of hydrophilic macromolecules like peptides and nucleic acids (e.g. siRNAs, aptamers and antisenseoligonucleotides), which are internalised by cells at a very low rate when applied alone. Up to now, numerous sequences have been reported to show cell-penetrating properties and many of them have been used to successfully transport a variety of different cargos into mammalian cells. In recent years, it has become apparent that endocytosis is a major route of internalisation even though the mechanisms underlying the cellular translocation of CPPs are poorly understood and still subject to controversial discussions. In this review, we will summarise the latest developments in peptide-based cellular delivery of nucleic acid cargos. We will discuss different mechanisms of entry, the intracellular fate of the cargo, correlation studies of uptake versus biological activity of the cargo as well as technical problems and pitfalls.">
    <entity charOffset="32-44" id="910a5b6256028ed6f3d360a28f14f49488b56db4.c1.e0" ontology_id="CHEBI_33696" text="nucleic acid" type="chemical"/>
    <entity charOffset="40-44" id="910a5b6256028ed6f3d360a28f14f49488b56db4.c1.e1" ontology_id="CHEBI_37527" text="acid" type="chemical"/>
    <entity charOffset="362-370" id="910a5b6256028ed6f3d360a28f14f49488b56db4.c1.e2" ontology_id="CHEBI_16670" text="peptides" type="chemical"/>
    <entity charOffset="497-502" id="910a5b6256028ed6f3d360a28f14f49488b56db4.c1.e3" ontology_id="CHEBI_46882" text="amino" type="chemical"/>
    <entity charOffset="497-508" id="910a5b6256028ed6f3d360a28f14f49488b56db4.c1.e4" ontology_id="CHEBI_33704" text="amino acids" type="chemical"/>
    <entity charOffset="503-508" id="910a5b6256028ed6f3d360a28f14f49488b56db4.c1.e5" ontology_id="CHEBI_37527" text="acids" type="chemical"/>
    <entity charOffset="606-620" id="910a5b6256028ed6f3d360a28f14f49488b56db4.c1.e6" ontology_id="CHEBI_33839" text="macromolecules" type="chemical"/>
    <entity charOffset="626-634" id="910a5b6256028ed6f3d360a28f14f49488b56db4.c1.e7" ontology_id="CHEBI_16670" text="peptides" type="chemical"/>
    <entity charOffset="639-652" id="910a5b6256028ed6f3d360a28f14f49488b56db4.c1.e8" ontology_id="CHEBI_33696" text="nucleic acids" type="chemical"/>
    <entity charOffset="647-652" id="910a5b6256028ed6f3d360a28f14f49488b56db4.c1.e9" ontology_id="CHEBI_37527" text="acids" type="chemical"/>
    <entity charOffset="667-675" id="910a5b6256028ed6f3d360a28f14f49488b56db4.c1.e10" ontology_id="CHEBI_140488" text="aptamers" type="chemical"/>
    <entity charOffset="1306-1318" id="910a5b6256028ed6f3d360a28f14f49488b56db4.c1.e11" ontology_id="CHEBI_33696" text="nucleic acid" type="chemical"/>
    <entity charOffset="1314-1318" id="910a5b6256028ed6f3d360a28f14f49488b56db4.c1.e12" ontology_id="CHEBI_37527" text="acid" type="chemical"/>
  </chunk>
</document>
